Review: taking Viibryd and Cymbalta together


Summary

Drug interactions are reported among people who take Viibryd and Cymbalta together. This review analyzes the effectiveness and drug interactions between Viibryd and Cymbalta. It is created by eHealthMe based on reports of 110 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Viibryd

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. (latest outcomes from Viibryd 4,869 users)

Cymbalta

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. (latest outcomes from Cymbalta 89,411 users)

On Sep, 16, 2016

110 people who take Viibryd, Cymbalta are studied.


Number of reports submitted per year:

Viibryd and Cymbalta drug interactions.

Drug effectiveness over time:

Viibryd:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Cymbalta:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Viibryd:
  • female: 0.0% - (0 of 9 people)
  • male: 0.0% - (0 of 0 people)
Cymbalta:
  • female: 11.0% - (1 of 9 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Viibryd:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 5 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Cymbalta:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 2 people)
  • 40-49: 0.0% - (0 of 4 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • depression
  • dystonia
  • nausea
  • pain in extremity
  • diarrhoea
  • insomnia
  • poor quality sleep
  • self injurious behaviour
  • tearfulness
  • abdominal discomfort
1 - 6 months:
  • dizziness
  • suicidal ideation
  • acne
  • anxiety
  • cold intolerance
  • depression
  • diarrhoea
  • dizziness exertional
  • drug ineffective
  • exaggerated startle response
6 - 12 months:
  • dizziness
  • nausea
  • depression
  • diarrhoea
  • feeling abnormal
  • headache
  • hypoaesthesia oral
  • abdominal discomfort
  • depressed mood
  • malaise
1 - 2 years:
  • arrhythmia
  • depressed level of consciousness
  • dizziness
  • dizziness exertional
  • exaggerated startle response
  • fatigue
  • food intolerance
  • gastritis
  • abnormal dreams
  • anxiety
2 - 5 years:
  • pancytopenia
  • hypoglycaemia
  • obesity
  • pre-existing condition improved
  • systemic lupus erythematosus
  • therapeutic response unexpected
  • weight decreased
5 - 10 years:
  • cold intolerance
not specified:
  • depression
  • diarrhoea
  • nausea
  • completed suicide
  • fatigue
  • insomnia
  • feeling abnormal
  • hyperhidrosis
  • cardio-respiratory arrest
  • headache

Most common drug interactions by gender *:

female:
  • depression
  • diarrhoea
  • nausea
  • feeling abnormal
  • headache
  • fatigue
  • insomnia
  • dizziness
  • syncope
  • suicidal ideation
male:
  • completed suicide
  • cardio-respiratory arrest
  • hyperhidrosis
  • hyperthermia
  • overdose
  • dystonia
  • pain in extremity
  • bradycardia
  • depression
  • hypotension

Most common drug interactions by age *:

10-19:
  • amnesia
  • confusional state
  • disturbance in attention
  • educational problem
  • euphoric mood
  • hearing impaired
  • insomnia
  • migraine
  • muscle tightness
  • panic attack
20-29:
  • abnormal dreams
  • arthralgia
  • depressed level of consciousness
  • fatigue
  • myalgia
  • polycystic ovaries
30-39:
  • dystonia
  • pain in extremity
  • convulsion
  • depression
  • insomnia
  • nausea
  • obesity
  • pre-existing condition improved
  • systemic lupus erythematosus
  • therapeutic response unexpected
40-49:
  • headache
  • fatigue
  • diarrhoea
  • acne
  • confusional state
  • feeling abnormal
  • suicidal ideation
  • anaemia
  • anxiety
  • autoimmune hepatitis
50-59:
  • completed suicide
  • nausea
  • cardio-respiratory arrest
  • diarrhoea
  • hyperhidrosis
  • hyperthermia
  • overdose
  • abdominal discomfort
  • depression
  • bradycardia
60+:
  • depression
  • insomnia
  • osteoporosis
  • angina pectoris
  • back pain
  • blood creatinine increased
  • bone density decreased
  • bone pain
  • diabetic nephropathy
  • diabetic retinopathy

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Viibryd and Cymbalta?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Viibryd, Cymbalta

You may be interested in these reviews

More reviews for: Viibryd, Cymbalta

On eHealthMe, Viibryd (vilazodone hydrochloride) is often used to treat depression. Cymbalta (duloxetine hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.